Search research articles
Contact Us
Filters
Showing results (431-440 of 456) with videos related to
Page
of 46
Sort By:
Scientific Reports
|
December 28, 2024
Diagnostic abnormalities, disease severity and immunotherapy responsiveness in individuals with Down syndrome regression disorder
Jonathan D Santoro, Saba Jafarpour, Laura Keehan, et al.
Cancers
|
December 24, 2021
The Transmembrane Receptor TIRC7 Identifies a Distinct Subset of Immune Cells with Prognostic Implications in Cholangiocarcinoma
Thomas Albrecht, Benjamin Goeppert, Fritz Brinkmann, et al.
Nature Immunology
|
March 31, 2010
The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses
Vijay A K Rathinam, Zhaozhao Jiang, Stephen N Waggoner, et al.
Blood Cells, Molecules & Diseases
|
October 29, 1998
Genetic and physical mapping of the Lps locus: identification of the toll-4 receptor as a candidate gene in the critical region
A Poltorak, I Smirnova, X He, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
December 22, 2012
IL-33-induced alterations in murine intestinal function and cytokine responses are MyD88, STAT6, and IL-13 dependent
Zhonghan Yang, Rex Sun, Viktoriya Grinchuk, et al.
The Journal of Experimental Medicine
|
November 20, 2020
A mouse model of human TLR4 D299G/T399I SNPs reveals mechanisms of altered LPS and pathogen responses
Katharina Richard, Kurt H Piepenbrink, Kari Ann Shirey, et al.
Cell Host & Microbe
|
September 18, 2012
Sustained generation of nitric oxide and control of mycobacterial infection requires argininosuccinate synthase 1
Joseph E Qualls, Chitra Subramanian, Wasiulla Rafi, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 19, 2025
First-in-class mitogen-activated protein kinase (MAPK) p38α: MAPK-activated protein kinase 2 dual signal modulator with anti-inflammatory and endothelial-stabilizing properties
Mohan E Tulapurkar, Kari Ann Shirey, Katerina Lugkey, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 16, 2024
First-in-Class Mitogen-Activated Protein Kinase p38α: MAPK-Activated Protein Kinase-2 (MK2) Dual Signal Modulator with Anti-inflammatory and Endothelial-stabilizing Properties
Mohan E Tulapurkar, Kari Ann Shirey, Katerina N Lugkey, et al.
American Journal of Medical Genetics. Part A
|
January 3, 2024
Safety and tolerability of intravenous immunoglobulin infusion in Down syndrome regression disorder
Jonathan D Santoro, Saba Jafarpour, Mellad M Khoshnood, et al.
Page
of 46
Search research articles
Search
Showing results (431-440 of 456) with videos related to
Sort By:
Page
of 46
Scientific Reports
|
December 28, 2024
Diagnostic abnormalities, disease severity and immunotherapy responsiveness in individuals with Down syndrome regression disorder
Jonathan D Santoro, Saba Jafarpour, Laura Keehan, et al.
Cancers
|
December 24, 2021
The Transmembrane Receptor TIRC7 Identifies a Distinct Subset of Immune Cells with Prognostic Implications in Cholangiocarcinoma
Thomas Albrecht, Benjamin Goeppert, Fritz Brinkmann, et al.
Nature Immunology
|
March 31, 2010
The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses
Vijay A K Rathinam, Zhaozhao Jiang, Stephen N Waggoner, et al.
Blood Cells, Molecules & Diseases
|
October 29, 1998
Genetic and physical mapping of the Lps locus: identification of the toll-4 receptor as a candidate gene in the critical region
A Poltorak, I Smirnova, X He, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
December 22, 2012
IL-33-induced alterations in murine intestinal function and cytokine responses are MyD88, STAT6, and IL-13 dependent
Zhonghan Yang, Rex Sun, Viktoriya Grinchuk, et al.
The Journal of Experimental Medicine
|
November 20, 2020
A mouse model of human TLR4 D299G/T399I SNPs reveals mechanisms of altered LPS and pathogen responses
Katharina Richard, Kurt H Piepenbrink, Kari Ann Shirey, et al.
Cell Host & Microbe
|
September 18, 2012
Sustained generation of nitric oxide and control of mycobacterial infection requires argininosuccinate synthase 1
Joseph E Qualls, Chitra Subramanian, Wasiulla Rafi, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 19, 2025
First-in-class mitogen-activated protein kinase (MAPK) p38α: MAPK-activated protein kinase 2 dual signal modulator with anti-inflammatory and endothelial-stabilizing properties
Mohan E Tulapurkar, Kari Ann Shirey, Katerina Lugkey, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 16, 2024
First-in-Class Mitogen-Activated Protein Kinase p38α: MAPK-Activated Protein Kinase-2 (MK2) Dual Signal Modulator with Anti-inflammatory and Endothelial-stabilizing Properties
Mohan E Tulapurkar, Kari Ann Shirey, Katerina N Lugkey, et al.
American Journal of Medical Genetics. Part A
|
January 3, 2024
Safety and tolerability of intravenous immunoglobulin infusion in Down syndrome regression disorder
Jonathan D Santoro, Saba Jafarpour, Mellad M Khoshnood, et al.
Page
of 46